by Prostate Cancer Center | Sep 15, 2024 | Prostate Cancer, Prostate Cancer, Prostate Treatment Miami
Did you know, a big lifestyle change you can make to reduce your risk of prostate cancer is to have more sex. That is right: more sex. Reduce Prostate Cancer Risk with Sexual Activity According to Johns Hopkins Medicine, staying sexually active can reduce your risk of...
by Prostate Cancer Center | May 15, 2024 | Prostate Cancer
The CyberKnife System is the only radiation delivery system that features a linear accelerator (linac) directly mounted on a robot to deliver the high-energy x-rays or photons used in radiation therapy. The robot moves and bends around the patient, to deliver...
by Prostate Cancer Center | Feb 15, 2024 | CyberKnife For Prostate Cancer, Prostate Cancer, Prostate Treatment Miami
“Will I ever be able to have sex again?” That is one of the first questions men ask their doctors after finding out they have prostate cancer and need treatment for it. It is understandably a big concern because the most common complaint for eight out of ten men...
by Prostate Cancer Center | Nov 1, 2023 | Prostate Cancer
According to two recent studies, a ‘decline in prostate-specific antigen screening’ or PSA blood test screening for prostate cancer may be why more men are being diagnosed with ‘advanced prostate cancer.’ The more advanced prostate cancer is when it is diagnosed,...
by Prostate Cancer Center | Oct 15, 2023 | Prostate Cancer
When it comes to radiation therapy for prostate cancer not all types of radiation are the same. And not all of them pack the same punch. Stereotactic body radiation therapy or SBRT sends targeted high-dose radiation to a specific part of the body – like the prostate –...
by Prostate Cancer Center | Oct 2, 2023 | Best Prostate Cancer Treatment, Metastatic Prostate Cancer, Oligometastatic Prostate Cancer, Prostate Cancer, SBRT for Prostate Cancer
Combining stereotactic body radiation therapy (SBRT), such as CyberKnife with standard systemic therapy yielded significant increases in the rates of biochemical response and progression-free survival (PFS) in patients with oligometastatic castrate-resistant prostate...
Recent Comments